Logo
x

Search

Subscribe Now

alzheimer’s

PharmaShots Interview: Zai Lab’s Jonathan Wang Shares Insights on KarXT (xanomeline-trospium) for the Treatment of Schizophrenia And Psychosis

PharmaShots Interview: Zai Lab’s Jonathan Wang Shares Insights on KarXT (xanomeline-trospium) for the Treatment of Schizophrenia A...

  • February 28, 2022
Enhancing Neurodegenerative Care: Stella Sarraf from Spinogenix in an Enlightening Dialogue Exchange with PharmaShots

    Enhancing Neurodegenerative Care: Stella Sarraf from Spinogenix in an Enlightening Dialogue Exchange with PharmaShots

    • October 14, 2024
    Sage Therapeutics Provides Data from the P-II (LIGHTWAVE) Trial of Dalzanemdor to Treat Mild Cognitive Impairment and Dementia in Alzheimer’s Disease

      Sage Therapeutics Provides Data from the P-II (LIGHTWAVE) Trial of Dalzanemdor to Treat Mild Cognitive Impairment and Dementia in...

      • October 8, 2024
      Life Molecular Imaging’s [18F] PI-2620 Gains the US FDA’s Fast Track Designation for PET Imaging in Various Neurodegenerative Disorders

        Life Molecular Imaging’s [18F] PI-2620 Gains the US FDA’s Fast Track Designation for PET Imaging in Various Neurodegenerative Diso...

        • August 29, 2024
        BioArctic and Eisai Receives MAA from MHRA for Leqembi (lecanemab) to Treat Early Alzheimer’s Disease (AD) in Great Britain

          BioArctic and Eisai Receives MAA from MHRA for Leqembi (lecanemab) to Treat Early Alzheimer’s Disease (AD) in Great Britain

          • August 22, 2024
          Lantheus Strengthens its Alzheimer’s Disease Pipeline Through the Acquisition of Meilleur Technologies

            Lantheus Strengthens its Alzheimer’s Disease Pipeline Through the Acquisition of Meilleur Technologies

            • July 16, 2024
            Neumora Therapeutics Commences the P-Ib Trial of NMRA-511 to Treat Agitation Due to Alzheimer’s Disease

              Neumora Therapeutics Commences the P-Ib Trial of NMRA-511 to Treat Agitation Due to Alzheimer’s Disease

              • June 21, 2024
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.